Management of depression and anxiety in COPD

European Respiratory Monograph

Volumn 59, Issue , 2013, Pages 144-163

  Cafarella, Paul A ^a   Effing, Tanja W ^a   Barton, Christopher ^b   Ahmed, David ^a   Frith, Peter Anthony ^a  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Anxiety; Comorbidities; COPD; Depression; Mental health assessment; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; BUSPIRONE; CITALOPRAM; DESIPRAMINE; DOPAMINE UPTAKE INHIBITOR; DOXEPIN; FLUVOXAMINE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; BLURRED VISION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; CONFUSION; CONSTIPATION; DELIRIUM; DEPRESSION; DIARRHEA; DISABILITY; DIZZINESS; DROWSINESS; DYSPNEA; ENVIRONMENTAL IMPACT; FATIGUE; GENERALIZED ANXIETY DISORDER; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; INSOMNIA; LACRIMATION; LENGTH OF STAY; MENTAL HEALTH; META ANALYSIS (TOPIC); MOOD DISORDER; MUSCLE TWITCH; MYALGIA; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PERIPHERAL EDEMA; PRACTICE GUIDELINE; PSYCHOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; RESTLESSNESS; RHINITIS; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DEFECT; SLEEP DISORDER; SMOKING; SOCIAL PHOBIA; SOMNOLENCE; SWEATING; SYSTEMATIC REVIEW (TOPIC); TREMOR; URINARY HESITANCY; URINE RETENTION; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 84874859290     PISSN: 1025448X     EISSN: 20756674     Source Type: Book Series    
DOI: 10.1183/1025448x.10012112     Document Type: Article

References (154)

1. Moussas G, Tselebis A, Karkanias A, et al. A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry 2008; 7: 7.
2. Yohannes AM. Depression and COPD in older people: a review and discussion. Br J Community Nurs 2005; 10: 42-46.
3. Global Strategy for the Diagnosis, Management, and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011. Available from: www.goldcopd.org Date last updated: February 21, 2012. Date last accessed: November 29, 2012.
4. Cafarella PA, Effing TW, Usmani ZA, et al. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology 2012; 17: 627-638.
5. National Institute for Health Clinical Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. NICE Clincal Guideline 101. London, NICE, 2010.
6. Holden L, Scuffham P, Hilton M, et al. Psychological distress is associated with a range of high-priority health conditions affecting working Australians. Aust NZ J Publ Health 2010; 34: 304-310.
7. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009; 38: 34-47.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edn. Washington, American Psychiatric Association, 2000.
9. National Institute for Health Clinical Excellence. Depression in adults: The treatment and management of depression in adults. NICE clinical guideline 90. London NICE, 2009.
10. National Institute for Health Clinical Excellence. Depression in adults with a chronic physical health problem: treatment and management. NICE clinical guideline 91. London, NICE, 2009.
11. National Institute for Health and Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. Management in primary, secondary and community care. NICE clinical guideline 113. London, NICE, 2011.
12. Hynninen MJ, Breitve MH, Wiborg AB, et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59: 429-443.
13. Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psych 2010; 25: 1209-1221.
14. Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol 2000; 10: 193-202.
15. Schane RE, Woodruff PG, Dinno A, et al. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Intern Med 2008; 23: 1757-1762.
16. Zhang MWB, Ho RCM, Cheung MWL, et al. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011; 33: 217-223.
17. Brenes G. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003; 65: 963-970.
18. Gorman JM, Coplan JD. Comorbidity of depression and panic disorder. J Clin Psychiatry 1996; 57: Suppl. 10, 34-41.
19. Liebowitz MR. Panic disorder as a chronic illness. J Clin Psychiatry 1997; 58: Suppl. 13, 5-8.
20. Marcus SC, Olfson M, Pincus HA, et al. Self-reported anxiety, general medical conditions, and disability bed days. Am J Psychiatry 1997; 154: 1766-1768.
21. Lecrubier Y. The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001; 62: Suppl. 8, 4-9.
22. Zöckler N, Rief W, Kuhl K, et al. COPD-specific anxiety and depressive symptoms in COPD patients. Pneumologie 2012; 66: 290-296.
23. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD. Chest 2008; 134: Suppl. 4, 43S-56S.
24. van Manen JG, Bindels PJE, Dekker FW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 412-416.
25. Katz PP, Julian LJ, Omachi TA, et al. The impact of disability on depression among individuals with COPD. Chest 2010; 137: 838-845.
26. Holm KE, La Chance HR, Bowler RP, et al. Family factors are associated with psychological distress and smoking status in chronic obstructive pulmonary disease. Gen Hosp Psychiat 2010; 32: 492-498.
27. Hanania N, Mullerova H, Locantore N, et al. Determinants of depression in the ECLIPSE COPD cohort. Am J Respir Crit Care Med 2011; 183: 604-611.
28. Garvey C. Depression in patients with chronic obstructive pulmonary disease. Postgrad Med 2012; 124: 101-109.
29. Ferguson DM. Comorbidity between depressive disorders and nicotine dependence in a cohort of 16 year olds. Arch Gen Psychiatry 1996; 53: 1043-1047.
30. Patton GC, Hibbert M, Rosier MJ, et al. Is smoking associated with depression and anxiety in teenagers? Am J Public Health 1996; 86: 225-230.
31. Diaz FJ, James D, Botts S, et al. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disord 2009; 11: 154-165.
32. Wiesbeck GA, Kuhl HC, Yaldizli O, et al. Tobacco smoking and depression - results from the WHO/ISBRA study. Neuropsychobiology 2008; 57: 26-31.
33. Schneider C, Jick SS, Bothner U, et al. COPD and the risk of depression. Chest 2010; 137: 341-347.
34. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149: 464-469.
35. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998; 17: 35-46.
36. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiat 1990; 31: 350-354.
37. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA 1990; 264: 1546-1549.
38. Mineur YS, Picciotto MR. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 2010; 31: 580-586.
39. Kendler KS, Neale MC, MacLean CJ, et al. Smoking and major depression. A causal analysis. Arch Gen Psychiatry 1993; 50: 36-43.
40. Ishii T, Wakabayashi R, Kurosaki H, et al. Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms. J Hum Genet 2011; 56: 41-46.
41. Mikkelsen RL, Middelboe T, Pisinger C, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58: 65-70.
42. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2006; 12: 113-117.
43. Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry 1998; 3: 115-130.
44. Grant I, Heaton RK, McSweeny AJ, et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982; 142: 1470-1476.
45. Areza-Fegyveres R, Kairalla RA, Carvalho CR, et al. Cognition and chronic hypoxia in pulmonary diseases. Dement Neuropsychol 2010; 4: 14-22.
46. Agustí A, Faner R. Systemic Inflammation and comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2012; 9: 43-46.
47. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of "overspill" of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65: 930-936.
48. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
49. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol 2003; 24: 444-448.
50. Cohen S, Tyrrell DA, Smith AP. Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol 1993; 64: 131-140.
51. Laurin C, Labrecque M, Dupuis G, et al. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med 2009; 71: 667-674.
52. Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011; 12: 1.
53. Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002; 53: 873-876.
54. Eagan TM, Ueland T, Wagner PD, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J 2010; 35: 540-548.
55. Marinho PEM, Castro CM, Raposo MC, et al. Depressive symptoms, inflammatory markers and body composition in elderly with and without chronic obstructive pulmonary disease (COPD). Arch Gerontol Geriatr 2012; 54: 453-458.
56. Dunlop DD, Lyons JS, Manheim LM, et al. Arthritis and heart disease as risk factors for major depression: the role of functional limitation. Med Care 2004; 42: 502-511.
57. Kohler CL, Fish L, Greene PG. The relationship of perceived self-efficacy to quality of life in chronic obstructive pulmonary disease. Health Psychol 2002; 21: 610-614.
58. McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002; 19: 47-53.
59. Penninx BW, van Tilburg T, Boeke AJ, et al. Effects of social support and personal coping resources on depressive symptoms: different for various chronic diseases? Health Psychol 1998; 17: 551-558.
60. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993; 50: 306-317.
61. Matthews AW. The relationship between central carbon dioxide sensitivity and clinical features in patients with chronic airways obstruction. Q J Med 1977; 46: 179-195.
62. Papp LA, Klein DF, Gorman JM. Carbon dioxide hypersensitivity, hyperventilation and panic disorder. Am J Psychiatry 1993; 150: 1149-1157.
63. Wemmie JA. Neurobiology of panic and pH chemosensation in the brain. Dialogues Clin Neurosci 2011; 13: 475-483.
64. Kircanski K, Craske MG, Epstein AM, et al. Subtypes of panic attacks: a critical review of the empirical literature. Depress Anxiety 2009; 26: 878-887.
65. Clark DM. A cognitive approach to panic. Behav Res Ther 1986; 24: 461-470.
66. Bailey PH. The dyspnea-anxiety-dyspnea cycle - COPD patients' stories of breathlessness: "It's scary when you can't breathe". Qual Health Res 2004; 14: 760-778.
67. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003; 65: 963-970.
68. Omachi TA, Katz PP, Yelin EH, et al. Depression and health related quality of life in chronic obstructive pulmonary disease. Am J Med 2009; 122: 778.
69. Jennings JH, Digiovine B, Obeid D, et al. The association between depressive symptoms and acute exacerbations of COPD. Lung 2009; 187: 128-135.
70. Cao Z, Ong KC, Eng P, et al. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11: 188-195.
71. Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67.
72. Von Korff M, Katon W, Rutter C, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med 2003; 65: 938-943.
73. Tselebis A, Bratis D, Kosmas E, et al. Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease. Arch Gen Psychiatry 2011; 10: 32.
74. Hill K, Geist R, Goldstein RS, et al. Anxiety and depression in end-stage COPD. Eur Respir J 2008; 31: 667-677.
75. Pommer AM, Pouwer F, Denollet J, et al. Managing co-morbid depression and anxiety in primary care patients with asthma and/or chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. Trials 2012; 13: 6.
76. Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001; 23: 77-83.
77. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15: 1090-1096.
78. Kellner R, Samet J, Pathak D. Dyspnea, anxiety, and depression in chronic respiratory impairment. Gen Hosp Psychiatry 1992; 14: 20-28.
79. Smith J, Albert P, Bertella E, et al. Qualitative aspects of breathlessness in health and disease. Thorax 2009; 64: 713-718.
80. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 896-901.
81. Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlations. Prim Care Respir J 2011; 20: 257-268.
82. Balcells E, Gea J, Ferrer J, et al. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Out 2010; 8: 108.
83. Meier C, Bodenmann G, Morgeli H, et al. Dyadic coping, quality of life and psychological distress among chronic obstructive pulmonary disease patients and their partners. Int J COPD 2011; 6: 583-596.
84. Regvat J, Zmitek A, Vegnuti M, et al. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res 2011; 39: 1028-1038.
85. Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chronic Resp Dis 2011; 8: 89-99.
86. Troosters T, Casaburi R, Gosselink R, et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 19-38.
87. Bosley CM, Corden ZM, Rees PJ, et al. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996; 9: 2346-2350.
88. Stapeleton RD, Nielsen EL, Engelberg RA, et al. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest 2005; 127: 328-334.
89. Reinke LF, Slatore CG, Udris EM, et al. The association of depression and preferences for life-sustaining treatments in veterans with chronic obstructive pulmonary disease. J Pain Symptom Manage 2011; 41: 402-411.
90. Janssen DJ, Spruit MA, Schols JM, et al. Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure. Chest 2012; 141: 1251-1259.
91. Coventry PA, Gemmell I, Todd CJ. Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study. BMC Pulm Med 2011; 11: 49.
92. Laurin C, Moullec G, Bacon SL, et al. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012; 185: 918-923.
93. Laurin C, Moullec G, Bacon SL, et al. The impact of psychological distress on exacerbation rates in COPD. Ther Adv Respir Dis 2011; 5: 3-18.
94. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008; 178: 913-920.
95. Abrams TE, Vaughan-Sarrazin M, Vander Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics 2011; 52: 441-449.
96. de Voogd JN, Wempe JB, Koëter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135: 619-625.
97. Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167: 2345-2353.
98. Goodwin RD. Is COPD associated with suicide behavior? J Psychiatr Res 2011; 45: 1269-1271.
99. Howard C, Hallas CN, Wray J, et al. The relationship between illness perception and panic in chronic obstructive pulmonary disease. Behav Res Ther 2009; 47: 71-76.
100. Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns 2011; 83: 29-36.
101. Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in chronic obstructive pulmonary disease. Eur Respir J 2010; 35: 557-563.
102. Kunik ME, Azzam PN, Souchek J, et al. A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics 2007; 48: 16-21.
103. Barth J, Schumacher M, Herrmann Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802-813.
104. Thombs BD, Magyar-Russell G, Bass EB, et al. Performance characteristics of depression screening instruments in survivors of acute myocardial infarction: review of the evidence. Psychosomatics 2007; 48: 185-194.
105. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
106. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
107. Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD - a review. Respir Med 2011; 105: 1422-1433.
108. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry 2000; 157: Suppl. 4, 1-45.
109. O'Hea E, Houseman J, Bedek K, et al. The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF. Heart Fail Rev 2009; 14: 13-20.
110. Fekete EM, Antoni MH, Schneiderman N. Psychosocial and behavioral interventions for chronic medical conditions. Curr Opin Psychiatry 2007; 20: 152-157.
111. Thomas PW, Thomas S, Hillier C, et al. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006; 1: CD004431.
112. Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol 2008; 13: 381-400.
113. Kunik ME, Veazey C, Cully JA, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008; 38: 385-396.
114. Lamers F, Jonkers CC, Bosma H, et al. Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. COPD 2010; 7: 315-322.
115. Ekers D, Richards D, Gilbody S. A meta-analysis of randomized trials of behavioural treatment of depression. Psychol Med 2008; 38: 611-623.
116. Klerman GL, Weissman MM, eds. New Applications of Interpersonal Psychotherapy. Washington, American Psychiatric Press, 1993.
117. Judd F, Weissman M, Davis J, et al. Interpersonal counselling in general practice. Aust Fam Physician 2004; 33: 332-337.
118. Lipsitz JD, Gur M, Vermes D, et al. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depress Anxiety 2008; 25: 542-553.
119. Miller MD. Using interpersonal therapy (IPT) with older adults today and tomorrow: a review of the literature and new developments. Curr Psychiatry Rep 2008; 10: 16-22.
120. Usmani ZA, Carson KV, Cheng JN, et al. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; 11: CD008483.
121. Light RW, Merrill EJ, Despars J, et al. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 1986; 146: 1377-1380.
122. Gordon GH, Michiels TM, Mahutte CK, et al. Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease. Psychiatry Res 1985; 15: 25-32.
123. Rayner L, Price A, Evans A, et al. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010; 3: CD007503.
124. Eiser N, Harte R, Spiros K, et al. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005; 2: 233-241.
125. Lacasse Y, Beaudoin L, Rousseau L, et al. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004; 61: 140-147.
126. Montgomery S. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients. Int Clin Psychopharmacol 1998; 13: Suppl. 5, S49-S54.
127. Rossi S, ed. Australian Medicines Handbook 2010. Adelaide, Australian Medicines Handbook Pty Ltd, 2010.
128. Spina E, Scordo MG. Clinically significant drug interactions with antidepressants in the elderly. Drugs Aging 2002; 19: 299-320.
129. Singh NP, Despars JA, Stansburg DW, et al. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 1993; 103: 800-804.
130. Subbe C, Collier GM, Bedson E, et al. Pilot study to examine the effect of citalopram on health status, anxiety and depression in patients with chronic obstructive pulmonary disease, ISRCTN41544517. www.controlledtrials.com Date last accessed: April 27, 2010.
131. Frith P, ed. A manual for pulmonary rehabilitation in Australia. Evidence base and standards. www.lungfoundation.com.au/images/stories/docs/copd/rehab_standards_v3_31_july_2008.pdf
132. McKenzie DK, Frith PA, Burdon JG, et al. The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Aust 2003; 178: Suppl. S7-S39.
133. Lacasse Y, Martin S, Lasserson TJ, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 2007; 43: 475-485.
134. Cecins N, Geelhoed E, Jenkins SC. Reduction in hospitalisation following pulmonary rehabilitation in patients with COPD. Australian Health Review 2008; 32: 415-422.
135. Bratas O, Espnes G, Rannestad T, et al. Pulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients - especially in patients with mild or moderate disease. Chron Respir Dis 2010; 7: 229-237.
136. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res 2007; 63: 551-565.
137. Reid WD, Yamabayashi C, Goodridge D, et al. Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews. Int J Chron Obstruct Pulmon Dis 2012; 7: 297-320.
138. Harrison SL, Greening NJ, Williams JE, et al. Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med 2012; 106: 838-844.
139. Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med 2009; 15: 143-149.
140. Bentsen SB, Wentzel-Larsen T, Henriksen AH, et al. Anxiety and depression following pulmonary rehabilitation. Scand J Caring Sci 2012 [Epub ahead of print DOI: 10.1111/j.1471-6712.2012.01064.x].
141. Paddison JS, Effing TW, Quinn S, et al. Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J 2012 [Epub ahead of print DOI: 10.1183/09031936.00021412].
142. Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry 1974; 37: 37-46.
143. Mandle CL, Jacobs SC, Arcari PM, et al. The efficacy of relaxation response interventions with adult patients: a review of the literature. J Cardiovasc Nurs 1996; 10: 4-26.
144. Devine EC, Pearcy J. Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ Couns 1996; 29: 167-178.
145. American Academy of Hospice and Palliative Medicine, Centre to Advance Palliative Care, Hospice and Palliative Nurses Association, et al. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for quality palliative care, executive summary. J Palliat Med 2004; 7: 611-627.
146. Morrison RS, Meier DE. Clinical practice. Palliative care. N Engl J Med 2004; 350: 2582-2590.
147. Aiken LS, Butner J, Lockhart CA, et al. Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J Palliat Med 2006; 9: 111-126.
148. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585-591.
149. Jonker AA, Comijs HC, Knipscheer KC, et al. Promotion of self-management in vulnerable older people: a narrative literature review of outcomes of the Chronic Disease Self-Management Program (CDSMP). Eur J Ageing 2009; 6: 303-314.
150. Lorig KR, Sobel DS, Ritter PL, et al. Effect of a self-management program on patients with chronic disease. Eff Clin Pract 2001; 4: 256-262.
151. Lamers F, Jonkers CC, Bosma H, et al. A minimal psychological intervention in chronically ill elderly patients with depression: a randomized trial. Psychother Psychosom 2010; 79: 217-226.
152. Effing T, Monninkhof EM, van der Valk PD, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007; 4: CD002990.
153. Effing T, Kerstjens H, van der Valk P, et al. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009; 64: 956-962.
154. Cockcroft A, Bagnall P, Heslop A, et al. Controlled trial of respiratory health worker visiting patients with chronic respiratory disability. Br Med J (Clin ResEd) 1987; 294: 225-228.